فهرست منابع و مراجع علمی خارجی | منابع و ماخذ:
# عنوان منبع و ماخذ
1 Oliveira AG, Santos A, Guerra JB, Rocha GA, Rocha AM, Oliveira CA, et al. babA2- and cagA-positive Helicobacter pylori strains are associated with duodenal ulcer and gastric carcinoma in Brazil. Journal of clinical microbiology. 2003;41(8):3964-6.
2 2. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Jama. 1994;272(1):65-9.
3 3. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer. 1994;61:1-241.
4 Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
5 Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 1996;335(4):242-9.
6 Peek RM, Jr., Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol. 2006;208(2):233-48.
7 Aviles-Jimenez F, Reyes-Leon A, Nieto-Patlan E, Hansen LM, Burgueno J, Ramos IP, et al. In vivo expression of Helicobacter pylori virulence genes in patients with gastritis, ulcer, and gastric cancer. Infect Immun. 2012;80(2):594-601.
8 Vinagre RM, Vilar-e-Silva A, Fecury AA, Martins LC. Role of Helicobacter pylori infection and lifestyle habits in the development of gastroduodenal diseases in a population from the Brazilian Amazon. Arquivos de gastroenterologia. 2013;50(3):170-4.
9 Olfat FO, Zheng Q, Oleastro M, Voland P, Boren T, Karttunen R, et al. Correlation of the Helicobacter pylori adherence factor BabA with duodenal ulcer disease in four European countries. FEMS immunology and medical microbiology. 2005;44(2):151-6.
10 Gerhard M, Lehn N, Neumayer N, Boren T, Rad R, Schepp W, et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proceedings of the National Academy of Sciences of the United States of America. 1999;96(22):12778-83.
11 Hessey SJ, Spencer J, Wyatt JI, Sobala G, Rathbone BJ, Axon AT, et al. Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut. 1990;31(2):134-8.
12 Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science. 1998;279(5349):373-7.
13 Nista EC, Candelli M, Cremonini F, Cazzato IA, Zocco MA, Franceschi F, et al. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Alimentary pharmacology & therapeutics. 2004;20(10):1181-8.
14 Homan M, Sterbenc A, Kocjan BJ, Luzar B, Zidar N, Orel R, et al. Prevalence of the Helicobacter pylori babA2 gene and correlation with the degree of gastritis in infected Slovenian children. Antonie van Leeuwenhoek. 2014;106(4):637-45.
15 Aspholm M, Olfat FO, Norden J, Sonden B, Lundberg C, Sjostrom R, et al. SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS pathogens. 2006;2(10):e110.
16 Mahdavi J, Sonden B, Hurtig M, Olfat FO, Forsberg L, Roche N, et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science. 2002;297(5581):573-8.
17 Unemo M, Aspholm-Hurtig M, Ilver D, Bergstrom J, Boren T, Danielsson D, et al. The sialic acid binding SabA adhesin of Helicobacter pylori is essential for nonopsonic activation of human neutrophils. The Journal of biological chemistry. 2005;280(15):15390-7.
18 Yamaoka Y. Increasing evidence of the role of Helicobacter pylori SabA in the pathogenesis of gastroduodenal disease. Journal of infection in developing countries. 2008;2(3):174-81.
19 Talebi Bezmin Abadi A, Taghvaei T, Mohabbati Mobarez A, Vaira G, Vaira D. High correlation of babA 2-positive strains of Helicobacter pylori with the presence of gastric cancer. Intern Emerg Med. 2013;8(6):497-501.
20 20. Eshaghi M. M, Ghasemian Safaei H. , PhD2 , Havaei AA. , PhD2 , Navabakbar F. , PhD2 , Salehi R. , PhD3 , Tavakoli H. , MD4 , Hasanzadeh A. , MSc Assessment of babA2 genotype frequency in H. Pylori and its relationship with digestive tract diseases in patients in Isfahan’s Alzahra Hospital. Scientific Journal of Kurdistan University of Medical Sciences, 2008(Issue 3). 2008.
21 Lai CH, Kuo CH, Chen YC, Chao FY, Poon SK, Chang CS, et al. High prevalence of cagA- and babA2-positive Helicobacter pylori clinical isolates in Taiwan. Journal of clinical microbiology. 2002;40(10):3860-2.
22 Han YH, Liu WZ, Zhu HY, Xiao SD. Clinical relevance of iceA and babA2 genotypes of Helicobacter pylori in a Shanghai population. Chinese journal of digestive diseases. 2004;5(4):181-5.
23 Yu J, Leung WK, Go MY, Chan MC, To KF, Ng EK, et al. Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions. Gut. 2002;51(4):480-4.
24 Yamaoka Y, Ojo O, Fujimoto S, Odenbreit S, Haas R, Gutierrez O, et al. Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut. 2006;55(6):775-81.
25 Zhang J, Dou C, Song Y, Ji C, Gu S, Xie Y, et al. Polymorphisms of tumor necrosis factor-alpha are associated with increased susceptibility to gastric cancer: a meta-analysis. J Hum Genet. 2008;53(6):479-89.
26 Sheu BS, Odenbreit S, Hung KH, Liu CP, Sheu SM, Yang HB, et al. Interaction between host gastric Sialyl-Lewis X and H. pylori SabA enhances H. pylori density in patients lacking gastric Lewis B antigen. Am J Gastroenterol. 2006;101(1):36-44.
|